Robson Araujo, DPM
Foot Surgery · Albertville, ALNPI 1548232374
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Prime Surgical, LLC at 42.1% of the total. Reporting peaked in 2024 at $1,146 and has fallen 97.2% since, to $32 in 2025.
Across 57 payments — averaging $53.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Prime Surgical, LLC$1K
- Smith+Nephew$340
- Organogenesis Inc.$276
- Kerecis Limited$264
- Arthrex$205
- Amgen$146
- plus $524 from 7 others
What the payments were for
- Speaking & faculty fees$602%
- Travel & lodging$1,43647%
- Food & beverage$1,53451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Prime Surgical, LLC | 2 | $1,275 |
| Smith+Nephew | 19 | $340 |
| Organogenesis Inc. | 8 | $276 |
| Kerecis Limited | 3 | $264 |
| Arthrex | 4 | $205 |
| Amgen | 2 | $146 |
| KCI USA, Inc. | 6 | $129 |
| Convatec Inc. | 1 | $104 |
| Stryker(2 entities) | 3 | $89 |
| Paratek Pharmaceuticals, Inc. | 5 | $74 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $73 |
| Solventum Corporation | 2 | $37 |
| Averitas Pharma Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,031 in reported general payments places this provider in the 75th percentile of 35 foot surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 28 | $65,530 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 19 | $607 |
| Gabapentin | 46 | $287 |
| Cefdinir | 18 | $275 |
| SsdSilver Sulfadiazine | 13 | $146 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $146 |
| Sodium Chloride0.9 % Sodium Chloride | 22 | $117 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Albertville
- Brooke GorhamGadsden$211K
- Eric FillingerCullman$19K
- John VanoreGadsden$17K
- Jean PrattGadsden$8K
- Robert RussellBirmingham$7K
- Richard HarrisBirmingham$6K
- James BowmanSylacauga$4K
- Stefan ZweigDothan$2K
- Michael McCollumMontgomery$2K
- Ronald AgeeBirmingham$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.